Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
108.17
+2.05 (1.93%)
At close: Aug 21, 2026, 4:00 PM EDT
108.40
+0.23 (0.21%)
After-hours: Aug 21, 2026, 7:20 PM EDT
Halozyme Therapeutics (HALO) Revenue by Segment
| Date | Royalties | Product Sales | Revenues Under Collaborative Agreements |
|---|---|---|---|
| Jun 30, 2026 | 1.04B | 476.94M | 144.41M |
| Mar 31, 2026 | 940.33M | 428.83M | 139.30M |
| Dec 31, 2025 | 867.84M | 376.44M | 152.33M |
| Sep 30, 2025 | 780.29M | 333.14M | 129.42M |
| Jun 30, 2025 | 699.31M | 325.57M | 153.79M |
| Mar 31, 2025 | 618.59M | 322.95M | 142.77M |
| Dec 31, 2024 | 570.99M | 303.49M | 140.84M |
| Sep 30, 2024 | 522.62M | 303.73M | 121.00M |
| Jun 30, 2024 | 482.00M | 303.64M | 87.67M |
| Mar 31, 2024 | 468.82M | 298.64M | 95.53M |
| Dec 31, 2023 | 447.87M | 300.85M | 80.53M |
| Sep 30, 2023 | 431.79M | 282.42M | 66.50M |
| Jun 30, 2023 | 416.91M | 257.27M | 99.47M |
| Mar 31, 2023 | 390.51M | 229.68M | 84.79M |
| Dec 31, 2022 | 360.48M | 191.03M | 108.61M |
| Sep 30, 2022 | 317.13M | 156.92M | 106.57M |
| Jun 30, 2022 | 276.14M | 120.54M | 90.80M |
| Mar 31, 2022 | 236.58M | 104.60M | 130.39M |
| Dec 31, 2021 | 203.90M | 104.22M | 135.19M |
| Sep 30, 2021 | 173.26M | 109.63M | 180.12M |